Total Payments
$6,221
2024 Payments
$4,285
Companies
28
Transactions
88
Medicare Patients
932
Medicare Billing
$153,519
Payment Breakdown by Category
Education$4,033 (64.8%)
Food & Beverage$2,188 (35.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $4,033 | 3 | 64.8% |
| Food and Beverage | $2,188 | 85 | 35.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $4,180 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $346.96 | 15 | $0 (2023) |
| Merck Sharp & Dohme LLC | $279.04 | 13 | $0 (2024) |
| TESARO, Inc. | $254.04 | 11 | $0 (2019) |
| Clovis Oncology, Inc. | $188.52 | 12 | $0 (2022) |
| Smith+Nephew, Inc. | $150.07 | 4 | $0 (2019) |
| Duchesnay USA Incorporated | $107.33 | 1 | $0 (2018) |
| DySIS Medical, Inc. | $99.97 | 1 | $0 (2017) |
| MINERVA SURGICAL, INC | $88.43 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $62.85 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,285 | 7 | INTUITIVE SURGICAL, INC. ($4,150) |
| 2023 | $134.05 | 5 | Merck Sharp & Dohme LLC ($75.29) |
| 2022 | $229.97 | 10 | GlaxoSmithKline, LLC. ($102.09) |
| 2021 | $238.96 | 11 | GlaxoSmithKline, LLC. ($63.83) |
| 2020 | $235.63 | 12 | GlaxoSmithKline, LLC. ($158.28) |
| 2019 | $287.26 | 16 | Clovis Oncology, Inc. ($67.74) |
| 2018 | $373.18 | 15 | TESARO, Inc. ($161.30) |
| 2017 | $436.68 | 12 | Smith & Nephew, Inc. ($123.32) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: Oncology | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | Cash or cash equivalent | $4,000.00 | General |
| Category: SURGERY | ||||||
| 03/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: SURGERY | ||||||
| 01/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: ONCOLOGY | ||||||
| 04/26/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $36.00 | General |
| Category: Oncology | ||||||
| 11/30/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ONCOLOGY | ||||||
| 05/05/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2022 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 04/11/2022 | Abbott Laboratories | I-STAT (Device) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Point of Care | ||||||
| 03/20/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $28.07 | General |
| 01/18/2022 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Oncology | ||||||
| 12/07/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ONCOLOGY | ||||||
| 09/08/2021 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 237 | 362 | $79,637 | $35,203 |
| 2022 | 5 | 249 | 334 | $87,142 | $39,209 |
| 2021 | 3 | 213 | 258 | $63,323 | $29,781 |
| 2020 | 6 | 233 | 386 | $129,554 | $49,326 |
Total Patients
932
Total Services
1,340
Medicare Billing
$153,519
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 20 | 20 | $35,075 | $13,740 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 139 | 263 | $18,410 | $12,019 | 65.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 42 | 42 | $5,922 | $3,550 | 59.9% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 11 | 11 | $13,992 | $2,800 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,006 | $1,882 | 47.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $2,232 | $1,212 | 54.3% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 23 | 23 | $39,813 | $16,085 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 108 | 177 | $19,116 | $11,027 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 53 | 53 | $8,056 | $5,460 | 67.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 53 | 69 | $5,037 | $3,541 | 70.3% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 12 | 12 | $15,120 | $3,097 | 20.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 154 | 199 | $25,748 | $14,866 | 57.7% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 17 | 17 | $29,388 | $10,418 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 42 | 42 | $8,187 | $4,498 | 54.9% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 23 | 23 | $54,266 | $16,836 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 179 | $28,525 | $15,095 | 52.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 105 | $12,897 | $6,345 | 49.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 38 | 38 | $9,356 | $4,671 | 49.9% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2020 | 11 | 11 | $17,655 | $3,232 | 18.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 25 | 30 | $6,855 | $3,147 | 45.9% |
About Dr. Joseph Rakowski, DO
Dr. Joseph Rakowski, DO is a Gynecology healthcare provider based in Grosse Pointe, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639389893.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Rakowski, DO has received a total of $6,221 in payments from pharmaceutical and medical device companies, with $4,285 received in 2024. These payments were reported across 88 transactions from 28 companies. The most common payment nature is "Education" ($4,033).
As a Medicare-enrolled provider, Rakowski has provided services to 932 Medicare beneficiaries, totaling 1,340 services with total Medicare billing of $153,519. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Grosse Pointe, MI
- Active Since 05/23/2007
- Last Updated 10/23/2020
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639389893
Products in Payments
- Da Vinci Surgical System (Device) $4,180
- ZEJULA (Drug) $530.63
- KEYTRUDA (Biological) $193.57
- Rubraca (Drug) $188.52
- PICO (Device) $123.32
- Osphena (Drug) $107.33
- DySIS V3 digital colposcope (Device) $99.97
- ENDOMETRIAL ABLATION SYSTEM (Device) $88.43
- LYNPARZA (Drug) $62.85
- VARUBI (Drug) $57.03
- LYNPARZA (Biological) $53.93
- TIVDAK (Biological) $51.08
- OVA1 (Device) $38.14
- Lenvima (Drug) $36.00
- INJECTAFER (Drug) $32.06
- I-STAT (Device) $31.42
- ETHICON (Device) $30.92
- PICO Single Use Negative Pressure Wound Therapy (Device) $26.75
- YONDELIS (Drug) $25.56
- vitagel (Device) $24.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.